TOCILIZUMAB
2 NDCs across 1 manufacturers|0 Generic,2 Brand
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$1001.12 – $1279.06
Up to 22% savings
7d Activity
2 flat
of 2 total NDCs
Market Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
1 manufacturer producing TOCILIZUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ACTEMRA ACTPEN 162 MG/0.9 ML | $1279.0578 per ML | — |
ACTEMRA 162 MG/0.9 ML SYRINGE | $1001.1205 per ML | — |